Table 6.
Comparison of published reports detailing characteristics of patients with brain metastases from malignant peripheral nerve sheath tumor (MPNST) and angiosarcoma.
| Case author | Age, sex | IB yr. | BM treatment | OS Mo |
|---|---|---|---|---|
| Malignant peripheral nerve sheath tumors | ||||
| Xu et al., 2012 [93] | 8 M | 14 | (None) | 16 |
| Flannery et al., 2010 [15] | 34 F | 36 | SR, WBRT, GKSRS | 48 |
| Tilgner et al., 2007 [92] | 60 M | 0a | SR, WBRT | Alive at 14 |
| Park et al., 2007 [101] | 21 M | 0a | SR, WBRT, Chemo | 16 |
| van Eck and Horstmann, 2006 [100] | 83 M | 108 | SR, GKSRS | 122 |
| Matyja et al., 2004 [94] | 33 M | ~56 | SR | ~60 |
| Yone et al., 2004 [104] | 4 M | 7 | WBRT | 21 |
| Oishi et al., 2000 [102] | 48 M | 61 | SR (en bloc) | NR |
| Maschke et al., 1999 [105] | 17 F | 0a | SR | NR |
| Probst-Cousin et al., 1997 [106] | 19 F | 156 | None | 157 |
| Haisa et al., 1996 [103] | 58 F | 180 | SR (en bloc) | 181 |
| Fenzi et al., 1995 [99] | 45 F | 5 | None | 18 |
| Seppälä and Haltia, 1993 [107] | 13 M | 2 | None | 2 |
| D'Angelo et al., 1991 [115] | 68 F | 24 | SR (en bloc) | 36 |
| Valdueza et al., 1991 [108] | 47 M | ~13 | None | 18 |
| Cras et al., 1990 [109] | 46 F | 0 | None | 0 |
| Hirose et al., 1989 [110] | 53 M | 15 | SR (en bloc), chemo | Alive at 20b |
| Hasegawa et al., 1984 [111] | 51 M | 2 | Biopsies | 3 |
| Macaulay, 1978 [112] | 18 M | 2 | None | 2 |
| White Jr., 1971 [113] | 20 M | NR | SR, radiation | 7 |
| D'Agostino et al., 1963 [114] | 22 F | NR | NR | 68 |
|
| ||||
| Angiosarcoma | ||||
| Liassides et al., 2004 [119] | 24 F | 3 | Palliative | 6 |
| Eguchi et al., 2002 [123] | 64 M | 19 | Palliative | 0 |
| Chami et al., 1994 [118] | 59 M | NR | Palliative | NR |
| Vaquero et al., 1990 [124] | 30 M | 4 | SR | 6 |
| Kuratsu et al., 1991 [117] | 17 M | — | SR | 12 |
| Haft et al., 1988 [80] | 31 F | — | WBRT | NR |
| Akutsu et al., 2004 [125] | 53 M | 2 | SR | 6 |
| Ellegala et al., 2002 [121] | 76 M | 24 | SR | 2 |
| Søndenaa et al., 1993 [126] | 73 F | 3 | Palliative | 3 |
| Gallo et al., 2001 [127] | 33 M | 12 | SR | 0 |
| Hassane et al., 2010 [128] | 48 M | 3 | Palliative | 0 |
| Simpson et al., 1989 [32] | 21 M | 24 | SR, WBRT | 26b |
| Angrish et al., 1979 [120] | 38 M | 3 | Palliative | 0 |
| Plotnik et al., 2008 [122] | 61 F | 60 | SR | NR |
| Chaudhuri et al., 1980 [129] | 31 F | 72 | SR, WBRT | 2 |
| Macaulay, 1978 [112] | 18 M | 2 | Palliative | 0 |
IB: interval to brain metastasis (mo); OS: overall survival in months; M: male; F: female; chemo: chemotherapy; SR: surgical resection; GKSRS: Gamma knife stereotactic radiosurgery; ICH: intracerebral hemorrhage on presentation; WBRT: whole brain radiotherapy; RT: radiotherapy; D: death prior to treatment; NR: not reported; NF: associated with neurofibromatosis type-1; abrain metastasis at initial presentation.; balive at last follow-up without recurrence.